Journal of Korean Medical Science

Korean Acad Medical Sciences (대한의학회)
권호 표지
DOI QR코드

DOI QR Code

Extraspinal Percutaneous Osteoplasty for the Treatment of Painful Bony Metastasis

  • Lee, Jae-Heon (Department of Biomedical Engineering, Pusan National University School of Medicine) ;
  • Kim, Su-Young (Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine) ;
  • Ok, Hwoe-Gyeong (Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine) ;
  • Kim, Tae-Kyun (Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine) ;
  • Kim, Kyung-Hoon (Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine)
  • Received : 2017.09.08
  • Accepted : 2017.12.15
  • Published : 2018.02.19
⟨ Previous Next ⟩

Abstract

Background: Extraspinal percutaneous osteoplasties (POPs) are novel techniques for the treatment of painful bony metastasis, which is often the cause of both persistent and incidental breakthrough pain. This retrospective study explored the efficacy and complications of extraspinal POPs. Methods: The origin of the cancer metastasis, performed POP sites, necessity of adjacent joint injections, pain and Karnofsky Performance Scale (KPS) scores, complications related to the POPs, and life expectancy were evaluated from the medical records from 2009 to 2016. Results: A total of 47 (M/F = 28/19) patients had received 54 POPs, including costoplasty, scapuloplasty, ilioplasty, humeroplasty, ischioplasty, femoroplasty, sternoplasty, and puboplasty, in order of frequency. The most common sites for the origin of the cancer, in order of frequency, were the lung, liver, breast, colon, and kidney. All patients receiving POPs including scapuloplasty, ilioplasty, humeroplasty, and femoroplasty needed adjacent joint injections before or after the POPs. Pain due to metastatic lesions was reduced significantly immediately after the POPs and the reduction was sustained until the end of their lives. The median KPS was increased from 35.4% to 67.7% immediately after the POPs. There were no complications related to the procedures. The mean life expectancy after performing the POPs, for 35 patients which died afterwards, was 99.3 days, ranging from 1 to 767 days. Conclusion: Even though pain in the isolated POP sites may be difficult to measure due to overlapping systemic pain, the POPs provided immediate local pain relief, and the patients showed better physical performance without procedure-related complications.

Keywords

Acknowledgement

Supported by : Pusan National University

References

  1. Galibert P, Deramond H, Rosat P, Le Gars D. Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty. Neurochirurgie 1987;33(2):166-8.
  2. Choi HR, Lee PB, Kim KH. Scapuloplasty alleviates scapular pain resulting from lung cancer metastasis. Pain Physician 2010;13(5):485-91.
  3. Kim KH. Preoperative motion-related pain in cancer patients with extraspinal metastases treated by percutaneous osteoplasty. J Anesth Clin Res 2011;4:276.
  4. Levine BD, Motamedi K, Chow K, Gold RH, Seeger LL. CT of rib lesions. AJR Am J Roentgenol 2009;193(1):5-13. https://doi.org/10.2214/AJR.08.1216
  5. Pyrgakis P, Panagouli E, Venieratos D. Anomalous origin and course of the suprascapular artery combined with absence of the suprascapular vein: case study and clinical implications. N Am J Med Sci 2013;5(2):129-33. https://doi.org/10.4103/1947-2714.107534
  6. Kim SY, Jung MW, Kim JM. The shoulder pain due to metastatic breast cancer: a case report. Korean J Pain 2011;24(2):119-22. https://doi.org/10.3344/kjp.2011.24.2.119
  7. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer 1948;1(4):634-56. https://doi.org/10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L
  8. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 2005;30(19):2186-91. https://doi.org/10.1097/01.brs.0000180401.06919.a5
  9. Martincic D, Brojan M, Kosel F, Stern D, Vrtovec T, Antolic V, et al. Minimum cement volume for vertebroplasty. Int Orthop 2015;39(4):727-33. https://doi.org/10.1007/s00264-014-2620-7
  10. Seo SS, Lee DH, Kim HJ, Yoon JW, Kwon OS, Kim KH. Percutaneous vertebroplasty at C7 for the treatment of painful metastases: a case report. Korean J Anesthesiol 2013;64(3):276-9. https://doi.org/10.4097/kjae.2013.64.3.276
  11. Joo YC, Ok WK, Baik SH, Kim HJ, Kwon OS, Kim KH. Removal of a vertebral metastatic tumor compressing the spinal nerve roots via a single-port, transforaminal, endoscopic approach under monitored anesthesia care. Pain Physician 2012;15(4):297-302.
  12. Yoon JY, Kim TK, Kim KH. Anterolateral percutaneous vertebroplasty at C2 for lung cancer metastasis and upper cervical facet joint block. Clin J Pain 2008;24(7):641-6. https://doi.org/10.1097/AJP.0b013e31816c6630
  13. Kim TK, Kim KH, Kim CH, Shin SW, Kwon JY, Kim HK, et al. Percutaneous vertebroplasty and facet joint block. J Korean Med Sci 2005;20(6):1023-8. https://doi.org/10.3346/jkms.2005.20.6.1023
  14. Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 2009;361(6):569-79. https://doi.org/10.1056/NEJMoa0900563
  15. Buchbinder R, Golmohammadi K, Johnston RV, Owen RJ, Homik J, Jones A, et al. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. Cochrane Database Syst Rev 2015;4(4):CD006349.
  16. Smith HS, Mohsin I. Painful boney metastases. Korean J Pain 2013;26(3):223-41. https://doi.org/10.3344/kjp.2013.26.3.223
  17. Yi YR, Lee NR, Kwon YS, Jang JS, Lim SY. Pulsed radiofrequency application for the treatment of pain secondary to sacroiliac joint metastases. Korean J Pain 2016;29(1):53-6. https://doi.org/10.3344/kjp.2016.29.1.53

Cited by

  1. Application of Percutaneous Osteoplasty in Treating Pelvic Bone Metastases: Efficacy and Safety vol.42, pp.12, 2018, https://doi.org/10.1007/s00270-019-02320-8